Medical News / AAAAI Congress 2021: What Is Needed to Improve Pediatric Asthma Controller Therapy Adherence

At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a late-breaking poster showed just more than half (57%) of pediatric patients with severe asthma adhered to their controller medication when monitored with a dose-administered feedback device. The findings, from a team at the Children’s Hospital Colorado, indicates even a high-risk population—who agreed to voluntary treatment monitoring, even—reports asthma controller adherence at a rate close to greater patient population averages. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ... read more
As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American ... read more
A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 ... read more
New research shows a recently revised diagnostic criteria is sufficient for emergency departments to identify and ... read more